Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Entacapone Tablets
Medication labelWhy this: Advisory · dailymed-prescription
Entacapone Tablets are indicated as an adjunct to levodopa and carbidopa to treat patients with idiopathic Parkinson’s Disease who experience the signs and symptoms of end-of-dose "wearing-off" (see CLINICAL PHARMACOLOGY, Clinical Studies). Entacapone Tablets’ effectiveness has not been systematically evaluated in patients with idiopathic Parkinson’s Disease who do not experience end-of-dose "wearing-off".
- generic_name
- entacapone
- product_names
- Entacapone
- ndc
- 55648-781, 55648-781-02, 55648-781-03
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en